Plus Therapeutics Inc Insider Trading

PSTV

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Nov 2025.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Nov 2025

Nov 4, 2025

Get an email when PSTV's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Nov 4, 2025	Andrew John Hugh Macintyre Sims Chief Financial Officer	Bought	20,000	$0.51	10K	42%	Form 4
Aug 22, 2025	Robert P Lenk Director	Bought	110,000	$0.49	54K	375%	Form 4

Nov 4, 2025
Andrew John Hugh Macintyre Sims
Chief Financial Officer · bought 20,000 at $0.51
10K
42% of stake
Aug 22, 2025
Robert P Lenk
Director · bought 110,000 at $0.49
54K
375% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch PSTV, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with PSTV

CompareIntrinsic value

INBSIntelligent Bio Solutions Inc.

$1.75-1.13%40

ICCMIceCure Medical Ltd.

$0.79+2.54%43

AURXNuo Therapeutics Inc.

$1.27+0.00%40

TNONTenon Medical Inc.

$1.91+1.06%40

USAQQHSLab Inc.

$0.32-15.00%49

LUCDLucid Diagnostics Inc.

$0.44+8.80%44

FEMYFemasys Inc.

$1.44+2.86%30

PMIPicard Medical, Inc.

$7.19-7.58%30

Spot a number that looks wrong? Check it in PSTV's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing PSTV

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.